SCHEMBL17367129

SCHEMBL17367129

c1ccc(-n2c3ccccc3c3c4ccc5c6ccccc6n(-c6ccccc6)c5c4sc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.52
ATM Q13315 2/20 0.52
KDM4E B2RXH2 1/20 0.52
HSD17B10 Q99714 2/20 0.36
KMT2A Q03164 4/20 0.34
MAPK8 P45983 2/20 0.34
IL1R1 P14778 1/20 0.34
ALDH1A1 P00352 4/20 0.33
MEN1 O00255 3/20 0.33
HTT P42858 2/20 0.33
MAPK1 P28482 2/20 0.33
MAPK9 P45984 1/20 0.33
MAPT P10636 1/20 0.33
PGR P06401 1/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
BRCA1 P38398 1/20 0.33
GAA P10253 1/20 0.33
FOLH1 Q04609 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367110 0.89 L3MBTL1 (0.41) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL17367163 0.89 KDM4E (0.40) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL17367160 0.88 KDM4E (0.42) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL17367107 0.88 KDM4E (0.41) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL17367159 0.87 L3MBTL1 (0.41) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL17690922 0.87 L3MBTL1 (0.59) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL17367158 0.87 L3MBTL1 (0.38) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL17367117 0.86 L3MBTL1 (0.41) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL17366958 0.85 L3MBTL1 (0.57) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL17367156 0.85 ATM (0.39) L3MBTL1ATMKDM4EHSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-18 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, CRY1, CYP1B1 L3MBTL1 717/4885ATM 3202/4885KDM4E 3404/4885
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same CYP1A1, CRY1, CYP1B1 L3MBTL1 717/4885ATM 3202/4885KDM4E 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.